- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT FLT4 represents a recently cloned member of class III receptor tyrosine kinases which include receptors for the angiogenic growth factor VEGF, namely FLT1 and KDR. The ligand of
FLT4 has been identified as VEGF-C which shares sequence homology with VEGF and P1GF. In the adult FLT4 shows a restricted expression pattern that is limited to lymphatic endothelia and
endothelia of some high endothelial venules (HEV). FLT4 has also been detected in some tumor cell lines including the hematopoietic line HEL. We therefore investigated expression of FLT4 and
its ligand VEGF-C in fresh samples from patients with AML. Using a sensitive PCR method we detected FLT4 m-RNA in 15 of 41 patients with _de novo_ AML at diagnosis or relapse and in three
of 12 patients with secondary AML. FLT4 expression was confirmed by immunocytochemistry in a subgroup of the studied patient population. FLT4 was also found in leukemic cell line U937, but
not TF-1 and KG1a. VEGF-C expression was found in leukemic samples of four of seven FLT4-positive and four of six FLT4-negative patients. U937 cells also produced VEGF-C m-RNA.
Interestingly, FLT4 expression was not detected in bone marrow samples of 15 normal volunteer donors or in CD34-positive cells from three additional donors. Possible autocrine and paracrine
growth stimulation of leukemic blasts by VEGF-C is currently being investigated in our laboratory. Access through your institution Buy or subscribe This is a preview of subscription content,
access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn
more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS
OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS THE IL-3, IL-5, AND GM-CSF COMMON RECEPTOR BETA
CHAIN MEDIATES ONCOGENIC ACTIVITY OF FLT3-ITD-POSITIVE AML Article Open access 08 November 2021 TARGETING _LMO2_-INDUCED AUTOCRINE FLT3 SIGNALING TO OVERCOME CHEMORESISTANCE IN EARLY T-CELL
PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Article Open access 23 January 2025 TLE4 IS A REPRESSOR OF THE ONCOGENIC ACTIVITY OF TLX3 IN T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA Article 21 January
2025 AUTHOR INFORMATION Author notes * U Graeven Present address: Medizinische Universitätsklinik Knappschaftskrankenhaus, In der Schornau 23-25, D-44892, Bochum, Germany AUTHORS AND
AFFILIATIONS * Department of Hematology/Oncology, University Hospital Eppendorf, Hamburg, Germany W Fielder, U Graeven, M Stockschläder & DK Hossfeld * Department of Institute of
Anatomy, University Hospital Eppendorf, Hamburg, Germany S Ergün, S Verago & N Kilic Authors * W Fielder View author publications You can also search for this author inPubMed Google
Scholar * U Graeven View author publications You can also search for this author inPubMed Google Scholar * S Ergün View author publications You can also search for this author inPubMed
Google Scholar * S Verago View author publications You can also search for this author inPubMed Google Scholar * N Kilic View author publications You can also search for this author inPubMed
Google Scholar * M Stockschläder View author publications You can also search for this author inPubMed Google Scholar * DK Hossfeld View author publications You can also search for this
author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Fielder, W., Graeven, U., Ergün, S. _et al._ Expression of FLT4 and its
ligand VEGF-C in acute myeloid leukemia. _Leukemia_ 11, 1234–1237 (1997). https://doi.org/10.1038/sj.leu.2400722 Download citation * Received: 21 December 1996 * Accepted: 03 April 1997 *
Issue Date: 01 August 1997 * DOI: https://doi.org/10.1038/sj.leu.2400722 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link
Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * AML * VEGF-C * FLT4 *
angiogenesis